Phase 3 Pneumococcal Infection Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
Bacterial InfectionsPneumococcal InfectionsStreptococcal Infections
CanSino Biologics Inc.600 enrolled3 locationsNCT07017777
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine
Pneumococcal InfectionsPneumococcal Vaccines
Beijing Minhai Biotechnology Co., Ltd500 enrolled3 locationsNCT06608199